South Carolina

South Carolina has rapidly emerged as a premier global life sciences hub, characterized by a top-tier research environment and a robust biomanufacturing infrastructure.

The state is best known for its specialized leadership in pharmaceutical manufacturing and medical device innovation, anchored by industry giants and a burgeoning startup culture.

Driven by a 42% growth rate in recent years, the South Carolina life sciences ecosystem now supports over 1,000 firms across sectors like biotechnology, health IT and precision medicine.

Central to this success is the collaboration between leading research universities, such as the University of South Carolina, Clemson University and MUSC, which fuel breakthroughs in oncology, neuroscience and advanced materials. These institutions work in tandem with the state's healthcare innovation initiatives to integrate AI-driven diagnostics and digital health solutions into clinical practice.

Strategic investments in cell and gene therapy (CGT) and radiotherapy have further solidified the region's reputation for specialty manufacturing.

With a pro-business climate and a highly skilled STEM workforce, the state offers an ideal landscape for venture capital investment and corporate expansion.

From drug discovery to 3D-printed medical implants, South Carolina is a powerhouse of biomedical research and clinical development. Consequently, the Palmetto State stands as a vital node in the global life sciences supply chain, offering unparalleled connectivity and scalability for international partners.